The British Society of Gastroenterology in collaboration with British Association for the Study
of the Liver has prepared this document. The aim of this guideline is to review and …

Background Palliative care remains suboptimal in end‐stage liver disease. Aim To inform a
definitive study, we assessed palliative long‐term abdominal drains in end‐stage liver …

Background & Aims The incidence and mortality from end‐stage liver disease is increasing,
with a minority eligible for liver transplantation. Ascites is the commonest complication of end…

Palliative care remains suboptimal in advanced cirrhosis, in part relating to a lack of
evidence-based interventions. Ascites remains the most common cirrhosis complication resulting in …

Direct‐acting antivirals (DAAs) have revolutionised the management of chronic hepatitis C
virus (HCV) infection. We describe UK real‐world DAA experience. Individuals commencing …

Background/aims Community‐based assessment and management of chronic liver disease
(CLD) in people who are homeless (PWAH) remain poorly described. We aimed to …

Context Palliative care remains suboptimal in end-stage liver disease (ESLD). Objectives
We report qualitative outcomes from the REDUCe study. We aimed to explore and contrast …

Background: Because of previous concerns about the efficacy and safety of oral iron for
treating iron deficiency anaemia in inflammatory bowel disease [IBD], particularly in young …

The coronavirus disease 2019 (COVID-19) pandemic has been associated with significant
morbidity and mortality. Following the introduction of vaccines, various side effects have been …

Background UK deaths due to chronic liver diseases such as cirrhosis have quadrupled
over the last 40 years, making this condition now the third most common cause of premature …